PKD1 and autosomal dominant polycystic kidney disease: Furthermore, understanding the genetic basis of kidney diseases enables the development of customized medicines, such as the study of inaxaplin (VX-407) for treating ADPKD in persons carrying specific PKD1 mutations [30,31,32,33].